Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx May Take Back Seat To “Corporate Responsibility”

Executive Summary

The renewed focus on corporate accounting issues may bring to an end the already slim chances that a Medicare prescription drug benefit will be enacted into law during 2002

You may also be interested in...



AdvancePCS Gives 80% Of Rebates To Clients, Sees Discounts Increasing

AdvancePCS retains less than 20% of manufacturer rebates, the pharmacy benefit management company told a July 25 conference call

AdvancePCS Gives 80% Of Rebates To Clients, Sees Discounts Increasing

AdvancePCS retains less than 20% of manufacturer rebates, the pharmacy benefit management company told a July 25 conference call

Rx Rebates, Gifts To Physicians Would Be Public Under Torricelli Proposal

Prescription drug rebates that manufacturers pay to PBMs would be public information under a legislative proposal by Sen. Bob Torricelli (D-N.J.)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel